Bone Biologics Corp
Nasdaq · CIK 0001419554 · Fiscal year end 1231
Latest reported period: Latest published period
Operating Income
$-805,054
Net Income
$-765,988
Eps Basic
-0.43
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-805,054 | - | - |
| Net Income | $-765,988 | - | - |
| Eps Basic | -0.43 | - | - |
| Eps Diluted | -0.43 | - | - |
| Total Assets | $5.0M | - | - |
| Total Liabilities | $309,386 | - | - |
| Shareholders Equity | $4.7M | - | - |
| Operating Cash Flow | $-804,282 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Bone Biologics Corp | 2026-05-14 | 0001493152-26-023163 |
| 10-K | Bone Biologics Corp | 2026-03-02 | 0001493152-26-008564 |
| 10-Q | Bone Biologics Corp | 2025-11-14 | 0001493152-25-023563 |
| 10-Q | Bone Biologics Corp | 2025-08-14 | 0001493152-25-011993 |